Bioceres Crop Solutions Corp. (BIOX) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Total · absolute moveSwitch to Alpha · Nasdaq
Bioceres Crop Solutions Corp. (BIOX) stock forecast summary
Our AI ranks Bioceres Crop Solutions Corp. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Its market capitalization is not available, so no size classification is given.
A per-ticker accuracy statistic for BIOX is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, BIOX included.
Follow BIOX freeBIOX price chart and AI forecast
How BIOX ranks among 4009 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Bioceres Crop Solutions Corp. (BIOX) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Agricultural Chemicals peers listed below that report each metric.
Financial statement data is not available for this company: its filings are not in a form the pipeline converts, so only market data is shown.
BIOX quarterly financials and insider trading
Bioceres Crop Solutions Corp. (BIOX) industry peers
Companies classified under the same SEC industry code as Bioceres Crop Solutions Corp. (Agricultural Chemicals): 12 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| BIOX Bioceres Crop Solutions Corp. | ▲ | N/A |
| NTR Nutrien Ltd. | ▼ | $33.89B |
| CF Cf Industries Holdings, Inc. | ▼ | $17.74B |
| ICL Icl Group Ltd. | ▼ | $6.43B |
| MOS Mosaic Co | ▼ | $6.10B |
| SMG Scotts Miracle-Gro Co | ▶ | $2.92B |
| UAN Cvr Partners, Lp | ▼ | $1.33B |
| AVD American Vanguard Corp | ▲ | $39M |
| BNET Bion Environmental Technologies Inc | ▲ | $9M |
| SNES Senestech, Inc. | ▲ | $3M |
| EVGN Evogene Ltd. | ▲ | $3M |
| CBUS Cibus, Inc. | ▲ | N/A |
Where BIOX sits on the market map
Bioceres Crop Solutions Corp. (BIOX) stock news
Loading...
Bioceres Crop Solutions Corp. (BIOX) stock forecast FAQ
What is the Bioceres Crop Solutions Corp. (BIOX) stock forecast?
Our AI ranks Bioceres Crop Solutions Corp. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Bioceres Crop Solutions Corp. stock predictions?
A per-ticker accuracy statistic for BIOX is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Bioceres Crop Solutions Corp. forecasts updated?
Bioceres Crop Solutions Corp. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Bioceres Crop Solutions Corp.'s industry peers?
12 issuers in our coverage, BIOX included, share the SEC industry code Agricultural Chemicals. The largest are: Nutrien Ltd. (NTR), Cf Industries Holdings, Inc. (CF), Icl Group Ltd. (ICL), Mosaic Co (MOS), Scotts Miracle-Gro Co (SMG), Cvr Partners, Lp (UAN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.